Samlyn Capital »

Arcus Biosciences Incorporated shares owned by Samlyn Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $38M 1.6M 23.83

More positions owned by Samlyn Capital

Lpl Financial Holdings (LPLA)
Bank of America Corporation (BAC)
Capital One Financial (COF)
Microsoft Corporation (MSFT)
Morgan Stanley Com New (MS)
First Solar (FSLR)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Core & Main Cl A (CNM)
NVIDIA Corporation (NVDA)
Rb Global (RBA)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
MercadoLibre (MELI)
Asml Holding N V N Y Registry Shs (ASML)

View all positions for Samlyn Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
Wellington Management Company
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
Balyasny Asset Management
Fisher Investments
Caption Management
Geode Capital Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated